MASI
Masimo Corporation NASDAQ$178.21
Mkt Cap $9.3B
52w Low $125.94
98.5% of range
52w High $179.00
50d MA $177.21
200d MA $152.72
P/E (TTM)
-63.1x
EV/EBITDA
21.0x
P/B
13.3x
Debt/Equity
0.8x
ROE
-21.0%
P/FCF
34.5x
RSI (14)
—
ATR (14)
—
Beta
1.20
50d MA
$177.21
200d MA
$152.72
Avg Volume
1.6M
About
Masimo Corporation develops, manufactures, and markets noninvasive monitoring technologies and hospital automation solutions worldwide. The company offers masimo signal extraction technology (SET) pulse oximetry with measure-through motion and low perfusion pulse oximetry monitoring to address the primary limitations of conventional pulse oximetry. It also provides Masimo rainbow SET platform that…
Recent Earnings
| Date | Time | Est | Rptd | Surp | Base | Gap% | D1% | D2% | D3% | D4% | D5% | Guide ▲★ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 26, 2026 | AMC | 1.48 | 0.18 | -87.8% | 175.22 | +0.0% | +0.1% | +0.1% | +0.1% | +0.1% | +0.1% | — |
| Nov 4, 2025 | AMC | 1.19 | 1.32 | +10.9% | 149.01 | +1.3% | -4.6% | -3.5% | -3.9% | -3.0% | -1.6% | — |
| Aug 5, 2025 | AMC | 1.23 | 1.33 | +8.1% | 163.88 | -0.5% | -11.7% | -11.6% | -11.7% | -10.1% | -8.4% | — |
| May 6, 2025 | AMC | 1.24 | 1.36 | +9.7% | 161.47 | -11.1% | -7.0% | -4.9% | -3.0% | +1.3% | +0.1% | — |
| Feb 25, 2025 | AMC | 1.42 | 1.80 | +26.8% | 169.54 | +11.2% | +12.3% | +9.8% | +11.3% | +12.4% | +8.2% | — |
| Nov 5, 2024 | AMC | 0.84 | 0.98 | +17.1% | 151.56 | +14.7% | +10.6% | +6.5% | +7.2% | +6.6% | +6.1% | — |
| Aug 6, 2024 | AMC | 0.77 | 0.86 | +11.7% | 110.32 | +7.5% | +11.3% | +16.0% | +15.0% | +15.8% | +16.4% | — |
| May 7, 2024 | AMC | 0.71 | 0.77 | +8.5% | 136.00 | -4.4% | -11.8% | -8.7% | -10.5% | -14.6% | -15.3% | — |
| Feb 27, 2024 | AMC | 0.95 | 1.25 | +31.6% | 130.10 | -4.7% | -1.1% | -1.2% | -2.8% | -2.5% | -0.4% | — |
| Nov 7, 2023 | AMC | 0.59 | 0.63 | +6.8% | 80.60 | -3.0% | +3.7% | +5.3% | +7.9% | +9.5% | +10.6% | — |
Recent Analyst Ratings
| Date | Firm | Action | Grade | Target | Base | Open | Gap% | D1% | D2% | D3% | D4% | D5% |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 27 | Raymond James | Downgrade | Outperform → Market Perform | — | $176.89 | $176.76 | -0.1% | +0.1% | +0.2% | +0.6% | +0.6% | +1.0% |
| Feb 18 | Wells Fargo | Downgrade | Overweight → Equal Weight | — | $174.69 | $174.80 | +0.1% | +0.5% | +0.4% | +0.2% | +0.3% | +0.4% |
| Feb 18 | BTIG | Downgrade | Buy → Neutral | — | $174.69 | $174.80 | +0.1% | +0.5% | +0.4% | +0.2% | +0.3% | +0.4% |
| Dec 4 | BTIG | Maintains | Buy → Buy | — | $138.09 | $138.27 | +0.1% | +3.0% | +2.6% | +2.0% | +0.4% | +1.2% |
| Nov 24 | BTIG | Maintains | Buy → Buy | — | $149.25 | $149.45 | +0.1% | -2.4% | -1.8% | -3.5% | -4.6% | -3.5% |
| Nov 5 | Wells Fargo | Maintains | Overweight → Overweight | — | $149.01 | $150.98 | +1.3% | -4.6% | -3.5% | -3.9% | -3.0% | -1.6% |
| Nov 5 | BTIG | Maintains | Buy → Buy | — | $149.01 | $150.98 | +1.3% | -4.6% | -3.5% | -3.9% | -3.0% | -1.6% |
| Sep 11 | BTIG | Maintains | Buy → Buy | — | $145.82 | $148.05 | +1.5% | +0.3% | +1.1% | -0.1% | -1.9% | -3.1% |
| Aug 6 | Piper Sandler | Maintains | Overweight → Overweight | — | $163.88 | $162.98 | -0.5% | -11.7% | -11.6% | -11.7% | -10.1% | -8.4% |
| May 7 | Wells Fargo | Maintains | Overweight → Overweight | — | $161.47 | $143.57 | -11.1% | -7.0% | -4.9% | -3.0% | +1.3% | +0.1% |
Recent Filings
8-K · 7.01
! Medium
Masimo Corporation -- 8-K 7.01: Regulation FD Disclosure
Masimo disclosed material information via press release that investors should review in Exhibit 99.1 for details on developments affecting the company and its parent Danaher.
May 4
8-K
Masimo Corporation -- 8-K Filing
Masimo faces three stockholder lawsuits challenging its merger with Danaher, filed after the definitive proxy statement was disclosed, potentially delaying or jeopardizing the transaction's completion.
Apr 23
8-K
Danaher Corporation -- 8-K Filing
Danaher reported Q1 2026 results from continuing operations, with year-over-year comparisons providing investors insight into the conglomerate's operational performance across its diversified portfolio.
Apr 21
8-K · 1.01
!!! Very High
Masimo Corporation -- 8-K 1.01: Merger Agreement
Danaher Corporation agreed to acquire Masimo Corporation, expanding Danaher's portfolio of patient monitoring and diagnostic devices through this significant healthcare technology consolidation.
Feb 17
8-K · 5.02
!!! Very High
Danaher Corporation -- 8-K 5.02: Executive Change
Danaher's appointment of a new executive signals potential strategic shifts in operations and governance; investors should monitor announcements regarding leadership responsibilities and company direction.
Feb 17
Data updated apr 25, 2026 8:35pm
· Source: massive.com